Retour
Fourchette du Jour
21,35 €
21,38 €
Fourchette 52 Semaines
5,64 €
21,44 €
Volume
1 702 720
Moyenne 50J / 200J
13,48 €
/
9,02 €
Clôture Précédente
21,44 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -20,6 | 0,4 |
| P/B | 5,0 | 2,9 |
| ROE % | -22,7 | 3,7 |
| Net Margin % | -67,9 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -104,08M
Capital efficient — spends only 0,20% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)20,60%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-22,74%
ROIC-21,58%
Net Margin-67,85%
Op. Margin-80,76%
Sécurité
Debt / Equity
0,01
Current Ratio8,02
Interest Coverage0,00
Valorisation
P/E Ratio
-20,56
P/B Ratio5,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,60% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 158,18M | Net Income (TTM) | -107,32M |
| ROE | -22,74% | ROA | -21,13% |
| Gross Margin | 89,12% | Operating Margin | -80,76% |
| Net Margin | -67,85% | Free Cash Flow (TTM) | -104,08M |
| ROIC | -21,58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 8,02 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -20,56 | P/B Ratio | 5,00 |
| P/S Ratio | 13,95 | PEG Ratio | -4,58 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,21B | Enterprise Value | 2,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 158,18M | 131,16M | 0,0 | 0,0 | 0,0 |
| Net Income | -107,32M | -95,50M | -188,92M | -142,18M | -70,65M |
| EPS (Diluted) | -1,04 | -1,02 | -2,37 | -2,02 | -1,14 |
| Gross Profit | 140,97M | 125,88M | -383 000,0 | -531 000,0 | -199 000,0 |
| Operating Income | -127,75M | -217,27M | -206,06M | -146,91M | -72,74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 507,83M | 582,79M | 376,05M | 349,06M | 289,82M |
| Total Liabilities | 66,67M | 80,04M | 29,51M | 17,02M | 8,67M |
| Shareholders' Equity | 441,16M | 502,75M | 346,54M | 332,04M | 281,15M |
| Total Debt | 2,79M | 2,60M | 408 000,0 | 813 000,0 | 220 000,0 |
| Cash & Equivalents | 197,08M | 124,97M | 230,78M | 85,26M | 284,31M |
| Current Assets | 485,10M | 562,33M | 375,27M | 347,87M | 289,37M |
| Current Liabilities | 60,52M | 73,45M | 29,51M | 16,62M | 8,66M |